Clinical Outcomes Related to Arthroscopic Rotator Cuff Repair Recovery Using Incrediwear
1 other identifier
interventional
140
1 country
1
Brief Summary
To assess the benefits of using the Incrediwear products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2024
CompletedFirst Posted
Study publicly available on registry
November 1, 2024
CompletedStudy Start
First participant enrolled
November 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 2, 2026
May 8, 2025
May 1, 2025
2.1 years
October 30, 2024
May 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Arm Circumference Measure with a Measuring tape
To measure swelling in the upper arm, a soft tape measure to measure the circumference of the arm at multiple points at the writs, mid-forearm, axilla, and oblique. A 2cm difference between arms at each area of the wrist, mid-forearm, axilla, and oblique shoulder is not optimal. Less than 2cm difference between arms at each area of the wrist, mid-forearm, axilla, and oblique shoulder is optimal.
Preop appointment, Postop Day 42, Day 84, Day 168, Day 364
Secondary Outcomes (2)
Visual Analogue Scale Measured by Scale
Preop appointment, Postop Day 42, Day 84, Day 168, Day 364
Range of Motion Measured by a Goniometer
Preop appointment, Postop Day 42, Day 84, Day 168, Day 364
Study Arms (2)
Placebo
PLACEBO COMPARATORTo assess the benefits of using the Incrediwear (Shoulder Sleeve) products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling. We will compare patients with Incrediwear products or placebo Incrediwear products throughout a 12-week period with follow-ups up to 1-year post-surgery. The study will be double blinded as to the active Incrediwear sleeve vs placebo.
Incrediwear Product
ACTIVE COMPARATORTo assess the benefits of using the Incrediwear (Shoulder Sleeve) products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling. We will compare patients with Incrediwear products or placebo Incrediwear products throughout a 12-week period with follow-ups up to 1-year post-surgery. The study will be double blinded as to the active Incrediwear sleeve vs placebo.
Interventions
One group will receive placebo therapy (identical shoulder brace and arm sleeve absent of semiconductor fabric)
One group will receive active therapy (active semiconductor embedded shoulder brace and arm sleeve)
Eligibility Criteria
You may qualify if:
- Patients undergoing arthroscopic rotator cuff repair
- Patients aged 18-75
- Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
- Patients who are willing and able to sign corresponding research subject consent form.
You may not qualify if:
- Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
- Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia
- Patient has had prior surgical treatment of a shoulder injury in the past 5 years
- Patient has chronic pain conditions unrelated to shoulder condition
- Patient has auto-immune or auto-inflammatory diseases
- Patient has used tobacco within the last 90 days
- Patient is not within the ages of 18-75
- Patient has poorly controlled diabetes with HgA1c \> 7.5
- Patient has an active infection (local or systemic)
- Patient is unwilling or unable to sign the corresponding research subject consent form
- Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
- Against medical advice (AMA)
- Prisoner as indicated in the medical record
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Texas Bone and Jointlead
- INCREDIWEAR HOLDINGS, INC.collaborator
Study Sites (1)
Medical City Denton
Denton, Texas, 76210, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher L. Flowers
Texas Bone and Joint
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic Surgeon
Study Record Dates
First Submitted
October 30, 2024
First Posted
November 1, 2024
Study Start
November 11, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 2, 2026
Last Updated
May 8, 2025
Record last verified: 2025-05